Latterell Venture Partners
Latterell Venture Partners (LVP) is an early-stage venture capital firm formed in 2001 that invests exclusively in healthcare ventures. The firm combines venture capital with technical, clinical, operational and entrepreneurial expertise from its partners to build biotechnology, pharmaceutical, research instrument, biomaterial, medical device, healthcare IT and diagnostics companies. LVP focuses on hands-on collaboration with founding teams, often leading or co-leading financings and serving on company boards to support development through exit.
Latterell Venture Partners
San Francisco, California, United States, North America
Services
Equity investments (lead or co-lead)
Lead or co-lead private equity investments in early-stage healthcare companies; initial checks typically range from $50,000 to $10 million with follow-on support and an expectation to invest $10–$20 million over a company's life.
Technical and clinical advisory
Hands-on technical and clinical guidance from partners with engineering, clinical trial and medical device experience to inform product development and regulatory strategy.
Operational and R&D support
Operational guidance derived from partners' prior R&D and executive roles, including assistance on research planning, product development and commercialization strategy.
Board participation and governance
Partners typically serve on portfolio company boards to provide governance, strategic oversight and sustained engagement.
Fundraising and investor syndicate formation
Assistance leading financings, constructing investor syndicates, and leveraging LVP's network to accelerate due diligence and close financings.
Recruiting and management support
Support recruiting senior management and, when needed, serving temporarily in executive roles to help launch companies.
Equity investments (lead or co-lead)
Lead or co-lead private equity investments in early-stage healthcare companies; initial checks typically range from $50,000 to $10 million with follow-on support and an expectation to invest $10–$20 million over a company's life.
Technical and clinical advisory
Hands-on technical and clinical guidance from partners with engineering, clinical trial and medical device experience to inform product development and regulatory strategy.
Operational and R&D support
Operational guidance derived from partners' prior R&D and executive roles, including assistance on research planning, product development and commercialization strategy.
Board participation and governance
Partners typically serve on portfolio company boards to provide governance, strategic oversight and sustained engagement.
Fundraising and investor syndicate formation
Assistance leading financings, constructing investor syndicates, and leveraging LVP's network to accelerate due diligence and close financings.
Recruiting and management support
Support recruiting senior management and, when needed, serving temporarily in executive roles to help launch companies.
Portfolio
Developed therapeutics for B cell-related cancers and immune diseases.
#Biotechnology / Immunology
Portfolio of products for gastrointestinal applications.
#Specialty Pharmaceuticals (G.I.)
Developed rapid measurement instruments for molecular binding.
#Research Instruments / Biotechnology tools
Commercializing rapid DNA analysis technology for forensic applications.
#Research Instruments / Forensics
Developed therapeutics for B cell-related cancers and immune diseases.
#Biotechnology / Immunology
Portfolio of products for gastrointestinal applications.
#Specialty Pharmaceuticals (G.I.)
Developed rapid measurement instruments for molecular binding.
#Research Instruments / Biotechnology tools
Commercializing rapid DNA analysis technology for forensic applications.
#Research Instruments / Forensics